drugset / Trial / NCT05549492

Transversus Abdominis Plane Block With or Without Buprenorphine After Inguinal Hernia Surgery

NCT05549492

Phase 1 Completed 64 enrolled Egymedicalpedia
RandomizedParallel-groupSingle-blindTreatment

Summary

Buprenorphine intravenous, sublingual, and transdermal patches have been researched for their antihyperalgesic effects, although peripherally mediated effects have not been examined in Egypt surprisingly

Timeline

Start
2021-01-01
Primary completion
2022-05-01
Completion
2022-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine 0.25%-NaCl 0.9% Injectable Solution Unknown 300 ug
Background Ropivacaine Other / unclassified 0.25 % Other
Background Ropivacaine Other / unclassified 20 ml Other

Indications

No indication recorded.